StockData

Research Alliance Corp III (RACC) stock

RACCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.07−0.05 (-0.49%)

Close on Nov 18, 2026Market cap $91.62MP/E –Yield –

Research Alliance Corp III operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$977.79K–
Q2 FY2026Jun 30, 2026-$184.42K–

More Research Alliance Corp III figures

See a number that looks wrong?